EGETIS THERAPEUTICS AB NPV earnings per share and revenue

0ABW earnings per share for the last quarter are -0.17 SEK whereas the estimation was -0.23 SEK which accounts for 27.66% surprise. Company revenue for the same period amounts to 12.70 M SEK despite the estimated figure of 12.70 M SEK. Estimated earnings per share for the next quarter are -0.20 SEK, and revenue is expected to reach 20.60 M SEK. Also watch annual changes over time to get a bigger picture of 0ABW earnings per share and revenue dynamics.